Back

High sensitivity CDC EUA SARS-CoV-2 kit-based End Point-PCR assay.

Freire-Paspuel, B.; Vega-Marino, P.; Velez, A.; Cruz, M.; Garcia Bereguiain, M. A.

2020-05-18 infectious diseases
10.1101/2020.05.11.20098590 medRxiv
Show abstract

SARS-CoV-2 diagnosis is based on RT-qPCR protocols that limited testing to facilities with Real Time PCR devices and probes supply. Here we described and adapted version of the RT-qPCR CDC protocol where N1, N2 and N3 primers are used for end point PCR and amplicons are visualized on agarose gel with a limit of detection up to 20 viral RNA copies/uL. This protocol would allow to extend SARS-CoV-2 diagnosis to basic molecular biology laboratories with a great impact on surveillance programs at developing countries.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.